Answers are grounded in this paper and cite their sources.
To the editor: Fingolimod (FTY720, 2-amino-2-propane-1,3-diol hydrochloride) is a remarkably efficient immunosuppressive drug that was recently approved as the first oral treatment for multiple sclerosis. Fingolimod prevents lymphocyte egress from lymph nodes by targeting 4 of 5 sphingosine-1-
No takes yet. Share an insight, caveat, or question.
Lorvik et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: